Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001214659-19-005669

EVP of R&D and CMO acquired 105,162 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Amado Rafael · EVP of R&D and CMO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-09-03 Grant or award : show line 1 in the form +105,162 105,162 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-09-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +160,630 160,630 D
Loading xslF345X03/marketforms-45677.xml…